Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
patent holder Regeneron, the drug achieved global sales of around $9 billion in 2023. Bayer and Regeneron are fighting hard to retain market exclusivity. The dispute spans numerous European countries
Edwards Lifesciences has secured an important victory before the Unified Patent Court in its long-running heart valve dispute. The Nordic-Baltic division confirmed the patent in amended form and
Context: Japanese courts have long stayed out of standard-essential patent (SEP) enforcement discussions – notably since a 2014 Apple v. Samsung IP High Court Grand Panel decision affirmed that while
patent dispute in the USA. Subject to the successful completion of the acquisition, all other proceedings between the parties concerning mRNA-based vaccines will also conclude. CureVac initiated the
with Celltrion over omalizumab. Today, the judges panel in Düsseldorf will hear a dispute between Ona Patents and Google concerning a patent relating to location-positioning technology in smartphones
Feb 6 (Reuters) - Genomics company 10x (TXG.O) and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into a scheduled two-week trial, according to a
can no longer sell some of its products. However, the dispute is expected to go to appeal. Two SMEs have pulled out all the stops to differentiate their products at the UPC. Dutch patent holder
Procter & Gamble (P&G) said it resolved its patent infringement dispute with Ranir, LLC regarding Ranir’s tooth whitening strip products in the United States and Canada. “This dispute was based on
COVID-19 vaccine was invalid. But the court ruled another similar patent was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to
Jan 15 (Reuters) - Gilead Sciences (GILD.O) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
